Inseparable from all Cognigenics’ activity is our initiative to address ethical considerations and challenges related to genetic engineering and CRISPR technology. We recognize these emerging fields are accompanied by significant ethical concerns and we are closely following these issues.
Our commitment to ethical practices ensures that our work in genetic engineering and CRISPR technology is conducted with the highest levels of responsibility and consideration for society’s well-being.
Genetic medicines should be developed and distributed in a way that ensures equitable access to all individuals, regardless of their socioeconomic status or geographic location.
SAFETY AND EFFICACY
Genetic medicines must undergo rigorous testing to ensure their safety and efficacy. The potential risks and benefits of genetic medicine should be carefully weighed and balanced to ensure that the benefits outweigh the potential harms.
The long-term effects of genetic medicine are not yet fully understood. It is important to ensure that genetic medicine is used responsibly and with a long-term view to safeguard the health and well-being of future generations.
RESPECT FOR AUTONOMY
Individuals have the right to make their own decisions about their healthcare. Genetic medicine should be developed and offered in a way that respects the autonomy of individuals and empowers them to make informed choices about their health.